CLSI POCT14

Point-of-Care Monitoring of Anticoagulation Therapy; Approved Guideline, POCT14AE

Clinical and Laboratory Standards Institute, 07/27/2020

Publisher: CLSI

File Format: PDF

$90.00$180.00

Description

Published:27/07/2020

Pages:68

File Size:1 file , 6.8 MB

Note:This product is unavailable in Russia, Belarus

This guideline provides recommendations to users and manufacturers of point-of-care coagulation testing devices for monitoring heparin and vitamin K antagonist therapy and for the evaluation of hemostasis, as well as to ensure reliable results comparable with those obtained by routine medical laboratory testing.

More CLSI standard pdf

CLSI M15A

Laboratory Diagnosis of Blood-borne Parasitic Diseases; Approved Guideline, M15-A

$90.00 $180.00

CLSI C29-A2

Standardization of Sodium and Potassium Ion-Selective Electrode Systems to the Flame Photometric Reference Method; Approved Standard, C29A2E

$141.00 $282.90

CLSI C34A2

Sweat Testing: Sample Collection and Quantitative Analysis; Approved Guideline, C34-A2

$114.00 $228.13

CLSI C39-A

A Designated Comparison Method for the Measurement of Ionized Calcium in Serum; Approved Standard, 39AE

$120.00 $241.91